Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Turn to the experienced analysts and deep wells of data at Informa Pharma Intelligence for all your clinical trial data needs. Our teams of subject matter experts deliver essential clinical trial data analysis, using data drawn from the most robust clinical trial database available.
Citeline, Pharmaprojects
17 Apr 2019
Take the analysis from the Informa Pharma Intelligence R&D Annual Review 2019 further with the Pharma R&D Annual Review 2019 Supplement: New Active Substances Launched During 2018. This essential whitepaper uses critical data from Pharmaprojects to examine the new entities that were successfully launched to market last year.
Citeline, Pharmaprojects
17 Apr 2019
For a snapshot of the new active substances (NAS) successfully launched last year, download the data-packed New Active Substances (NAS) Launched During 2018 infographic from Citeline.
Datamonitor Healthcare
By Michael Haydock 15 Apr 2019
Mr. Haydock & Mr. Haas used the exclusive information within Datamonitor Healthcare and Biomedtracker to present a view of the market for HIV drugs. Informa Pharma Intelligence forecasts HIV sales revenues to increase in the US and five major EU markets to a peak of $22.7bn in 2024 before generic erosion triggers a market decline.
Datamonitor Healthcare
By Niharika Dandamudi 15 Apr 2019
Lysosomal storage diseases (LSDs) are a rare distinct group of disorders with complex diagnosis and limited epidemiology data, such as Pompe disease. In recognition of International Pompe Day, marked on April 15, we created the below infographic to provide some insight into epidemiology and present an overview of current treatment options.
Topic Diseases
Scrip
By Mike Ward 15 Apr 2019
A staple of consumer magazines and tabloid newspapers involves coverage of celebrity relationships – who has been seen together? Who is dating? Will they become a permanent item? And are they going to live happily ever after? Readers can’t seem to get enough of it. Interestingly, while maybe not so racy as the celebrity goings-on, pharma industry watchers are keen to follow company couplings. Talk of mergers and acquisitions, one of the ways that companies can build scale, always attracts attention.
Scrip
By Jessica Merrill 11 Apr 2019
Drug makers remained front and center during the Senate Finance Committee's third hearing on drug pricing, even though leaders from five pharmacy benefit managers were testifying.
Scrip
By Mandy Jackson 11 Apr 2019
Private Company Edition: Biotech companies raised $3.9bn, down from $4.6bn in the first quarter of 2019 – a record-breaking year in the US – but dollars per deal stayed above $20m for a second year. Also, Fusion has April's second $100m-plus VC financing with a $105m Series B.
Topic BioPharmaceutical
In Vivo
By Lucie Ellis 11 Apr 2019
As Bayer prepares for several of its key products to lose patent exclusivity in four to five years’ time, In Vivo caught up with the company’s new head of pharma, Stefan Oelrich, to hear more on his strategy for the future – especially his plans for drug R&D, collaboration and a pipeline built on external innovation.
HBW Insight
By Malcolm Spicer 11 Apr 2019
In four days before Scott Gottlieb's stint as commissioner ended, FDA announced official start of initiative to consider regulatory pathways to make CBD compliant as a dietary ingredient, launched another shot across kratom sector's bow and noted more examples of e-cigarette marketers crossing regulatory lines.
Topic FDA
Pink Sheet
By Cathy Kelly 11 Apr 2019
Reform "is going to happen,” promised Energy & Commerce Oversight Subcommittee Chair Diana DeGette, suggesting the panel’s next hearing on insulin price reform may be held in July.
Topic Diabetes
Medtech Insight
By Sue Darcey 11 Apr 2019
US House Representatives Ron Kind, D-Wis., and Jackie Walorski, R-Ind., have introduced a permanent medical device tax-repeal bill, alongside 225 co-sponsors from both parties.
Topic Medtech
Medtech Insight
By Ferdous Al-Faruque 11 Apr 2019
International regulators are interested in seeing how they too can apply the US FDA’s precertification program, which is currently in the pilot stage. In an exclusive interview with Medtech Insight, the agency’s top digital health officer, Bakul Patel, talks about global curiosity about the program that could allow companies to get certain medical software on the market based on trust. Patel also expects an upcoming artificial intelligence draft guidance from the FDA will form from a recent discussion paper – but he says industry needs to do more.
Topic Medtech
Datamonitor Healthcare
10 Apr 2019
This essential whitepaper looks at how increased drug spending and a rising desire for expenditure controls are influencing access dynamics across key markets. It is available to you now, for free.
Datamonitor Healthcare
10 Apr 2019
These reports includes 20-year forecasts of prevalent type 1 and type 2 diabetes cases segmented by age and gender, and drug-treated diabetes, segmented by treatment type.
Topic Diabetes
Pink Sheet
10 Apr 2019
As a CRO professional, you need to stay abreast of the issues and news that can have a profound effect on your clients’ clinical trials. For essential insights into these types of R&D and regulatory matters, turn to the accurate and comprehensive information and analysis from Pink Sheet.
Topic Clinical trials Research
Medtech Insight
26 Apr 2019
Pink Sheet
25 Apr 2019
Scrip
25 Apr 2019
Scrip
25 Apr 2019
Pink Sheet
25 Apr 2019
Pink Sheet
25 Apr 2019
Pink Sheet
25 Apr 2019
Pink Sheet
25 Apr 2019
Pink Sheet
25 Apr 2019
Pink Sheet
25 Apr 2019
Scrip
25 Apr 2019
Medtech Insight
25 Apr 2019
Pink Sheet
25 Apr 2019
Scrip
25 Apr 2019
Scrip
25 Apr 2019
Approximately 400,000 investigators in over 170 countries, all with clinical trial experience, all at your fingertips. Support your trial success and inform your principal investigator (PI) and site selection activities with Sitetrove, now on a sleek, modern interface for simpler, faster and more efficient searching.
Key benefits:
Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.
Key benefits:
The industry’s most trusted drug development database, Citeline's Pharmaprojects has been covering pharma R&D across global markets for 35+ years. With 68,000+ drug profiles including 15,000 drugs in active development, it’s the go-to resource for preclinical, clinical, and pipeline coverage, and lifecycle management tracking.
Key benefits:
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
